Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone.

International journal of chronic obstructive pulmonary disease

Volumn 5, Issue , 2010, Pages 311-318

  Balint, Beatrix ^a   Watz, Henrik ^b   Amos, Carolynn ^b   Owen, Roger ^b   Higgins, Mark ^b   Kramer, Benjamin ^b   INSURE Study Investigators, ^b  

^a Csongrád Megyei OnkormányzatMellkasi Betegségek Szakkórháza   (Hungary)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 (5,6 DIETHYLINDAN 2 YLAMINO) 1 HYDROXYETHYL) 8 HYDROXY 1H QUINOLIN 2 ONE; 5-(2-(5,6-DIETHYLINDAN-2-YLAMINO)-1-HYDROXYETHYL)-8-HYDROXY-1H-QUINOLIN-2-ONE; ANDROSTANE DERIVATIVE; BRONCHODILATING AGENT; DRUG DERIVATIVE; FLUTICASONE; INDAN DERIVATIVE; QUINOLONE DERIVATIVE; SALBUTAMOL; SALMETEROL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG POTENTIATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUINOLONES;

EID: 78449277970     PISSN: None     EISSN: 11782005     Source Type: Journal    
DOI: None     Document Type: Article

References (0)